Search Results

John Streicher About this episode Our guest in this episode of the Dr.GPCR podcast is Dr. John Streicher from the department of pharmacology at the University of Arizona. John started grad school in 1999 and spent some time figuring out what he was interested in. Today, John and his team focus on understanding how signal transduction cascades downstream of the opioid John Streicher on the web University of Arizona Department of Pharmacology Google Scholar Pubmed LinkedIn

John Janetzko About Dr. John's scientific content. John's Chemistry Olympiad Journey John shared his experiences in high school, where he developed a keen John's Chemistry Olympiad and GPCR Journey John shared his experience with the Chemistry Olympiad program John's Scientific Journey and Lab Collaboration John discussed his scientific journey, starting with

Authors and Affiliations John Stagg , David Allard . About John Stagg "John Stagg is a Professor of Pharmacy at Université de Montréal and researcher at the John Stagg on the web University of Montréal Québec Cancer Consortium The University of Montreal Hospital

GPCR About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery Currently serving as a Post Doctoral research fellow at Monash University, John plays a pivotal role Clinical Research Associate at IQVIA and regulatory officer at the Food and Drug Authority (FDA) in Ghana, John Driven by a passion for advancing drug development, John is committed to leveraging his expertise to John Azietaku on the web LinkedIn Dr.

Jennifer is currently an assistant professor of physiology at the Johns Hopkins School of Medicine. Jennifer Pluznick on the web John Hopkins Pluznick Lab Pubmed Ted Talk Dr.

In November 2021, I joined Dr. the Johns Hopkins School of Medicine to work as a lab tech in a neurophysiology lab investigating mechanisms I then joined Boston University to pursue my scientific career as PhD student and joined the lab of Dr Receptor Pharmacology About Meredith Skiba "Meredith completed her PhD in Biological Chemistry with Janet Smith She then joined Andrew Kruse’s lab for her postdoc in 2018 where she has employed protein engineering

Smith About Dr. Nicola J. Smith Dr. Nicola J Smith is an expert in molecular pharmacology with a track record in exploring GPCR structure-function Smith’s team has made advances in the understanding of how an orphan GPCR exerts its effects both in Smith on the web UNSW Sydney LinkedIn Retraction Watch Twitter Dr. GPCR Ecosystem Enjoying the Dr.

During a joint postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the He then joined WL/PD, where his lab demonstrated the existence of two subtypes of the adenosine A2 receptor In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.

About Eric Johansen "I will be a 6th year Ph.D student in the chemical biology interface program at Johns Eric Johansen on the web Johns Hopkins University Dr.

He then went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs

John Traynor , Kathryn worked to develop and understand first-in-class allosteric modulators of opioid

progressed through the ranks at Warwick to become an Associate Professor before leaving in 2015 to join the Department of Pharmacology at Cambridge, where he is also a Fellow of St John’s College.

After that, I worked at Johns Hopkins in Baltimore as a research assistant investigating mechanisms and

He has also been the recipient of multiple awards, including the John J. Lastly, they touched on a project with Nicola Smith that challenged their previous theories.

Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns

Randy then joined the faculty at the Emory University School of Medicine in 1999. Keck Foundation, and the John J. Abel Award from ASPET . Join me to learn more about Randy’s work, hear his insights on the GPCR field, and also hear the story

Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns

Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns

He trained at the University of California at Berkeley with John Forte and the University of Washington with Bertil Hille, before joining Kim Tolias' lab at Baylor College of Medicine."

a final year PhD candidate in the Orphan Receptor Laboratory headed by Associate Professor Nicola J Smith

John Traynor and Dr.

From his early work as a technician at Johns Hopkins Hospital to leading biology at Servo Therapeutics

In 2017 I officially joined the PhD program in the Department of Molecular Physiology and Biophysics Since I joined the lab, I became proficient in many In-vivo techniques, I adapted my arrestin recruitment John McCorvy , Dr. Dylan Eiger , and Joshua Gross. We are very excited about this event.

Articles Kiyan Afzali The Perils and Guardrails of Modifying Signalling Proteins in Bioassays Read More John

Chris Evans at UCLA.

Oliver Smithies at UNC-CH, where she was the first to discover the essential role of adrenomedullin peptide

Oliver Smithies at UNC-CH, where she was the first to discover the essential role of adrenomedullin peptide

He joined Mount Sinai through FlexMed — bypassing the MCAT — and was torn between a career in pharma About Alex Serafini Alex was born and raised in the Bay Area and received his BS/MS Neuroscience from Johns Upon matriculating to Mount Sinai's MD/PhD program, he joined Dr.

He has also been the recipient of multiple awards, including the John J.

He has also been the recipient of multiple awards, including the John J.